Ami Organics Ltd
NSE:AMIORG

Watchlist Manager
Ami Organics Ltd Logo
Ami Organics Ltd
NSE:AMIORG
Watchlist
Price: 2 299.35 INR 7.6% Market Closed
Market Cap: 94.1B INR
Have any thoughts about
Ami Organics Ltd?
Write Note

Ami Organics Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ami Organics Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Ami Organics Ltd
NSE:AMIORG
Note Receivable
â‚ą5.5m
CAGR 3-Years
-22%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Note Receivable
â‚ą2.3B
CAGR 3-Years
-11%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Note Receivable
â‚ą3.3B
CAGR 3-Years
1 392%
CAGR 5-Years
45%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Note Receivable
â‚ą10.9B
CAGR 3-Years
-35%
CAGR 5-Years
-18%
CAGR 10-Years
-2%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Note Receivable
â‚ą2.3B
CAGR 3-Years
87%
CAGR 5-Years
18%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Note Receivable
â‚ą1.5B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ami Organics Ltd
Glance View

Market Cap
94.1B INR
Industry
Pharmaceuticals

Ami Organics Ltd. engages in the development and commercialization of pharmaceutical intermediate products. The company is headquartered in Surat, Gujarat and currently employs 561 full-time employees. The company went IPO on 2021-09-14. These specialty chemicals with varied end usage, focus on the development and manufacturing of pharma intermediates for regulated and generic active pharmaceutical ingredient (APIs) and new chemical entity (NCEs). The company manufactures pharma intermediates for certain APIs, including dolutegravir, trazodone, entacapone, nintedanib and rivaroxaban. The pharma intermediates, which the Company manufactures have application in certain high-growth therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant. The company has developed and commercialized over 450 pharma intermediates for APIs and NCEs across 17 therapeutic areas. Its specialty chemicals have applications in the agrochemicals and fine chemicals industries. The firm supplies its products to more than 150 customers directly in India.

AMIORG Intrinsic Value
1 495.1 INR
Overvaluation 35%
Intrinsic Value
Price

See Also

What is Ami Organics Ltd's Note Receivable?
Note Receivable
5.5m INR

Based on the financial report for Mar 31, 2024, Ami Organics Ltd's Note Receivable amounts to 5.5m INR.

What is Ami Organics Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-13%

Over the last year, the Note Receivable growth was -26%. The average annual Note Receivable growth rates for Ami Organics Ltd have been -22% over the past three years , -13% over the past five years .

Back to Top